At a glance
- Originator Daiichi Pharmaceutical
- Class Anti-ischaemics; Antiplatelets; Cardiotonics; Small molecules
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Ischaemic heart disorders
Most Recent Events
- 19 Dec 2000 Discontinued-II for Heart failure in Japan (Unknown route)
- 19 Dec 2000 Discontinued-II for Ischaemic heart disorders in Japan (Unknown route)